(Q34094929)

31 July 2017

1 reference

title

Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy (English)

1 reference

31 July 2017

Danesi R

1

1 reference

31 July 2017

Mosca M

2

1 reference

31 July 2017

Boggi U

3

1 reference

31 July 2017

Mosca F

4

1 reference

31 July 2017

Del Tacca M

5

1 reference

31 July 2017

language of work or name

1 reference

1 December 2000

1 reference

Trends in Molecular Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

6

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

475-482

1 reference

Skin cancer in liver transplant recipients

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Cancers in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Immunosuppressive drugs: the first 50 years and a glance forward

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Current opinions on therapeutic drug monitoring of immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Pharmacogenetics and the practice of medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

The 14-3-3 proteins positively regulate rapamycin-sensitive signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Interactions of calcineurin A, calcineurin B, and Ca2+

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Mutations That Perturb Cyclophilin A Ligand Binding Pocket Confer Cyclosporin A Resistance in Saccharomycescerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

FK506 binding protein mutational analysis. Defining the surface residue contributions to stability of the calcineurin co-complex

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Azathioprine associated T-cell mutations in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

P-glycoprotein and drug therapy in organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Neoral use in the cardiac transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

The impact of immunosuppressive drugs on the analysis of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Studies on the mechanism of resistance to rapamycin in human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

Future challenges in immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2800%2901822-0

7 January 2021

10.1016/S1357-4310(00)01822-0

Identifiers

DOI

1 reference

31 July 2017

1 reference